United Therapeutics Corporation (NASDAQ:UTHR)‘s stock had its “outperform” rating reissued by Wedbush in a research report issued to clients and investors on Wednesday. They presently have a $229.00 price target on …
Middle East
Last week's bullish sentiment carried over into the first session of the new week as investors decidedly pushed the stock market to new record highs ... FMS, GOV, TPH, UTHR, SO, ADPT, AVA, NI, ARCC, CLH, CRTO, …
and United Therapeutics Corp. (UTHR). Making the Powerhouse list is …
Balance sheet
As of the close of trading Friday, every short seller was sitting on a loss. This may provide additional volatility to the stock. Trading history: In 2011, UTHR joined the ranks of stocks that spiked high in the Y2K era but …
United Therapeutics Corporation (NASDAQ:UTHR)‘s stock had its “buy” rating reissued by investment analysts at Oppenheimer Holdings, Inc. in a note issued to investors on Tuesday. Several other research firms have also …
and RESEARCH TRIANGLE PARK, N.C., Feb. 22, 2017 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) today announced its financial ... Revenues Includes expense related to restricted stock
Financial Results
In a a report released on Tuesday, 29 November, stock analysts at Barclays’s equities division cut United …
A stock is considered to be oversold if the RSI reading falls below 30. In trading on Tuesday, shares of United Therapeutics Corp (NASD: UTHR) entered into oversold territory, hitting an RSI reading of 29.4, after changing …
AQR Capital Management LLC now owns 1,584,113 shares of the biotechnology company’s stock valued at $167,790,000 after buying an additional 277,266 shares during the last quarter. Shares of United Therapeutics …
Includes expense related to restricted stock units for the year ended December 31, 2016 and employee stock
United Airlines